NL-OMON49529已完成不适用
Towards a smart and intuitive controlled MyLeg prosthesis: acquisition of intramuscular electromyography for motion intention detection. A pilot study. - MyLeg: motion intention detection based on intramuscular EMG and TMR
Revalidatiecentrum Het Roessingh0 个研究点目标入组 15 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Transfemoral amputees with targeted muscle reinnervation:
- •- Aged 18 or above.
- •- Unilateral transfemoral amputation.
- •- At least one year after osseointegration implant surgery.
- •- At least six months after TMR surgery and visible contractions (by
- •ultrasound) of the TMR sites.
- •- Functional level defined as Medicare Functional Classification Level K2 to K4:
- •o Level 2: The patient has the ability or potential for ambulation with the
- •ability to traverse low-level environmental barriers such as curbs, stairs, or
- •uneven surfaces. Typical of the limited community ambulator.
- •o Level 3: The patient has the ability or potential for ambulation with
- •variable cadence. Typical of the community ambulatory who has the ability to
- •traverse most environmental barriers and may have vocational, therapeutic, or
- •exercise activity that demands prosthetic utilization beyond simple locomotion.
- •o Level 4: The patient has the ability or potential for prosthetic ambulation
- •that exceeds basic ambulation skills, exhibiting high impact, stress, or energy
- •levels. Typical of the prosthetic demands of the child, active adult, or
- •- Able to perform low to moderate vigorous physical activity for a duration of
- •1 hour including breaks.
- •Transfemoral amputees:
- •- Aged 18 or above.
- •- Unilateral transfemoral amputation.
- •- At least one year after osseointegration implant surgery.
- •- Functional level defined as Medicare Functional Classification Level K2 to K4
- •[12]; see description above.
- •- Able to perform low to moderate vigorous physical activity for a duration of
- •1 hour including breaks.
- •Able-bodied:
- •- Aged 18 or above.
- •- Able to perform low to moderate vigorous physical activity for a duration of
- •1 hour including breaks.
排除标准
- •Transfemoral amputees (with targeted muscle reinnervation):
- •- Not willing to consent to participate in the study.
- •- Other musculoskeletal problems influencing walking abilities.
- •- Stump problems: untreated skin conditions, wounds, infections, or problems
- •affecting walking ability.
- •- Taking coumarin-derivatives and having an INR > 3.0. (Subjects with an INR *
- •3.0 or using NOACs will be included in the study, and informed about the
- •slightly increased bleeding risk.)
- •- Have had amputation because of infection and/or bad wound healing.
- •Able-bodied:
- •- Not willing to consent to participate in the study.
- •- Musculoskeletal problems influencing walking ability.
- •- Taking coumarin-derivatives and having an INR > 3.0. (Subjects with an INR *
- •3.0 or using NOACs will be included in the study, and informed about the
- •slightly increased bleeding risk.)
研究者
相似试验
Unknown
不适用
Towards MY smart and intuitive controlled LEG prosthesisNL-OMON27197Roessingh Research and Development70
已完成
不适用
Towards MY smart and intuitive controlled LEG prosthesis: acquisition of electromyography for motion intention detectio.v.t.AmputationIndividuals without an amputation10005944NL-OMON55509Revalidatiecentrum Het Roessingh80
招募中
Unknown
SmartSense4Life - Configurable electronics platform forindividualized rehabilitation after stroke andspinal cord injuryG82.3G82.4G82.5Flaccid tetraplegiaSpastic tetraplegiaTetraplegia, unspecifiedDRKS00032591niversitätsklinikum Heidelberg - Klinik für Paraplegiologie - Sektion Experimentelle Neurorehabilitation3
招募中
不适用
Implementation of Predictive Intelligent Control of Oxygenation (PRICO®) on High Flow Nasal Cannula Support in preterm infants.Prematurity. BPD.NL-OMON23497MMC Veldhoven, The Netherlands25
尚未招募
不适用
Artificial intelligence and smart application for diagnosis of pediatric skin diseasesAcne vulgaris, Atopic dermatitis, Seborrheic dermatitis, Irritant contact dermatitis, Psoriasis vulgaris, Xerosis cutis, Vitiligo, Cafe au lait spots, Melanocytic nevi, Congenital non-neoplastic nevusArtificial intelligence, pediatric skin diseasesTCTR20210816003Office of the National Digital Economy and Society Commission500